Select for export Can Psychedelics Radically Change SUD Treatment? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2020.2a12 Copy citation Copy BibTeX Psychiatric News 2020-03-19 Katie O’Connor OpenAlex Published psilocybin AnxietyPTSDAddiction Clinical Trial More
Select for export A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2020.02.001 PubMed 32146028 Copy citation Copy BibTeX European Neuropsychopharmacology 2020-03-03 M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120908004 PubMed 32108529 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-02-27 Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, Rotem Petranker, Lê-Anh Dinh-Williams, Katrina Hui OpenAlex Published psilocybin AnxietyAddictionMicrodosing Randomized Controlled Trial More
Select for export P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.12.087 Copy citation Copy BibTeX European Neuropsychopharmacology 2020-01-27 Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes OpenAlex Published psilocybin General Other More
Select for export Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119895520 PubMed 31941394 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-15 Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionChronic PainBrain Imaging Other More
Select for export Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119897615 PubMed 31916890 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-08 Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-019-05391-0 PubMed 31784805 Copy citation Copy BibTeX Psychopharmacology 2019-12-31 Moreton SG, Szalla L, Menzies RE, Arena AF PubMed Published psilocybin AnxietyMechanism of ActionWellbeing Review Article More
Select for export A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/hup.2719 PubMed 31909513 Copy citation Copy BibTeX Human Psychopharmacology Clinical and Experimental 2019-12-31 Joseph J. Palamar, Patricia Acosta OpenAlex Published psilocybin PharmacologyToxicity Qualitative Study More
Select for export P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.271 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange OpenAlex Published psilocybin PharmacologyOxidative Stress Other More
Select for export P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.232 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel OpenAlex Published psilocybin Receptor PharmacologyPersonality Change Other More
Select for export P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.593 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris OpenAlex Published psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial More
Select for export P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.702 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2019-08-12 King's College London ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingPharmacologyMechanism of Action Other More
Select for export Replication and extension of a model predicting response to psilocybin No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-019-05279-z PubMed 31203401 Copy citation Copy BibTeX Psychopharmacology 2019-06-14 Suzanne L. Russ, Robin Carhart-Harris, Geoffrey Maruyama, Melody S. Elliott OpenAlex Published psilocybin AnxietyPharmacologyToxicity Other More
Select for export Motives and Side-Effects of Microdosing With Psychedelics Among Users Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyz029 PubMed 31152167 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2019-05-29 Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers OpenAlex Published psilocybin PharmacologyMicrodosingObservational Study Observational Study More
Select for export Psychedelic Medicine: Careful Studies, Regulations Are the Answer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2019.5a25 Copy citation Copy BibTeX Psychiatric News 2019-04-29 Paul Summergrad OpenAlex Published psilocybin Brain ImagingPharmacologyMechanism of Action Other More
Select for export Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-019-0324-9 PubMed 30685771 Copy citation Copy BibTeX Neuropsychopharmacology 2019-01-25 M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen OpenAlex Published psilocybinpsilocin PharmacologyReceptor Pharmacology Other More
Select for export Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000253 PubMed 30628811 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2019-01-09 Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus OpenAlex Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export Psilocybin induces aberrant prediction error processing for tactile mismatch responses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.477 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 P. Dürler OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.474 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel OpenAlex Published psilocybinpsilocin Receptor Pharmacology Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.